title: Marrow cell genetic phenotype change induced by human lung cancer cells.
abstract: Microvesicles have been shown to mediate varieties of intercellular communication. Work in murine species has shown that lung-derived microvesicles can deliver mRNA, transcription factors, and microRNA to marrow cells and alter their phenotype. The present studies evaluated the capacity of excised human lung cancer cells to change the genetic phenotype of human marrow cells. We present the first studies on microvesicle production by excised cancers from human lung and the capacity of these microvesicles to alter the genetic phenotype of normal human marrow cells. We studied 12 cancers involving the lung and assessed nine lung-specific mRNA species (aquaporin, surfactant families, and clara cell-specific protein) in marrow cells exposed to tissue in co-culture, cultured in conditioned media, or exposed to isolated lung cancer-derived microvesicles. We assessed two or seven days of co-culture and marrow which was unseparated, separated by ficoll density gradient centrifugation or ammonium chloride lysis. Under these varying conditions, each cancer derived from lung mediated marrow expression of between one and seven lung-specific genes. Microvesicles were identified in the pellet of ultracentrifuged conditioned media and shown to enter marrow cells and induce lung-specific mRNA expression in marrow. A lung melanoma and a sarcoma also induced lung-specific mRNA in marrow cells. These data indicate that lung cancer cells may alter the genetic phenotype of normal cells and suggest that such perturbations might play a role in tumor progression, tumor recurrence, or metastases. They also suggest that the tissue environment may alter cancer cell gene expression.
authors.affiliation: Department of Medicine, Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Del Tatto
authors.forename: Thomas
authors.initials: T
authors.lastname: Ng
authors.forename: Jason M
authors.initials: JM
authors.lastname: Aliotta
authors.forename: Gerald A
authors.initials: GA
authors.lastname: Colvin
authors.forename: Mark S
authors.initials: MS
authors.lastname: Dooner
authors.forename: David
authors.initials: D
authors.lastname: Berz
authors.forename: Gerri J
authors.initials: GJ
authors.lastname: Dooner
authors.forename: Elaine F
authors.initials: EF
authors.lastname: Papa
authors.forename: Douglas C
authors.initials: DC
authors.lastname: Hixson
authors.forename: Bharat
authors.initials: B
authors.lastname: Ramratnam
authors.forename: Bassam I
authors.initials: BI
authors.lastname: Aswad
authors.forename: Edmund H
authors.initials: EH
authors.lastname: Sears
authors.forename: John
authors.initials: J
authors.lastname: Reagan
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Quesenberry
mesh_terms: D001854:Bone Marrow Cells / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D002450:Cell Communication / Q000235:genetics*; D018920:Coculture Techniques; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008168:Lung / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology; D010641:Phenotype; D011506:Proteins / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis
chemical_list: D011506:Proteins; D012333:RNA, Messenger